The DOI matches its Crossref record; 157 of the 157 references it cites were found in a registry or an index.
Clinical actionability of molecular targets in endometrial cancer
Open accessAbstract
Endometrial cancer accounts for ~76,000 deaths among women each year worldwide. Disease mortality and the increasing number of new diagnoses make endometrial cancer an important consideration in women's health, particularly in industrialized countries, where the incidence of this tumour type is highest. Most endometrial cancers are carcinomas, with the remainder being sarcomas. Endometrial carcinomas can be classified into several histological subtypes, including endometrioid, serous and clear cell carcinomas. Histological subtyping is currently used routinely to guide prognosis and treatment decisions for endometrial cancer patients, while ongoing studies are evaluating the potential clinical utility of molecular subtyping. In this Review, we summarize the overarching molecular features of endometrial cancers and highlight recent studies assessing the potential clinical utility of specific molecular features for early detection, disease risk stratification and directing targeted therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the combined presence of PTEN and PIK3CA or PIK3R1 mutations are frequently observed suggesting that both loss of tumor suppressor and activation of oncogenes is required during tumor progression53.”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [53]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Le, D. T., Durham, J. N., Smith, K. N., Wang, H., Bartlett, B. R., Aulakh, L. K., Lu, S., Kemberling, H., Wilt, C., Luber, B. S., et al. (2017) · Science · doi:10.1126/science.aan6733 · Cited by 6,645
The Immune Landscape of Cancer
Thorsson, V., Gibbs, D. L., Brown, S. D., Wolf, D., Bortone, D. S., Ou Yang, T.-H., Porta-Pardo, E., Gao, G. F., Plaisier, C. L., Eddy, J. A., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.03.023 · Cited by 5,870
Integrated genomic characterization of endometrial carcinoma
The Cancer Genome Atlas Research Network, & Levine, D. A. (2013) · Nature · doi:10.1038/nature12113 · Cited by 5,784
Nieto, M. A., Huang, R. Y.-J., Jackson, R. A., & Thiery, J. P. (2016) · Cell · doi:10.1016/j.cell.2016.06.028 · Cited by 4,492
Zehir, A., Benayed, R., Shah, R. H., Syed, A., Middha, S., Kim, H. R., Srinivasan, P., Gao, J., Chakravarty, D., Devlin, S. M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4333 · Cited by 3,380
Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens
Behan, F. M., Iorio, F., Picco, G., Gonçalves, E., Beaver, C. M., Migliardi, G., Santos, R., Rao, Y., Sassi, F., Pinnelli, M., et al. (2019) · Nature · doi:10.1038/s41586-019-1103-9 · Cited by 1,338
Confirmation of ProMisE: A simple, genomics‐based clinical classifier for endometrial cancer
Talhouk, A., McConechy, M. K., Leung, S. C. Y., Yang, W., Lum, A. M., Senz, J., Boyd, N., Pike, J. A., Anglesio, M. S., Kwon, J. S., et al. (2017) · Cancer · doi:10.1002/cncr.30496 · Cited by 1,007
A clinically applicable molecular-based classification for endometrial cancers
Talhouk, A., McConechy, M. K., Leung, S. C. Y., Li-Chang, H. H., Kwon, J. S., Melnyk, N., Yang, W., Senz, J., Boyd, N., Karnezis, A. N., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.190 · Cited by 989
Stelloo, E., Nout, R. A., Osse, E. M., Jurgenliemk-Schulz, I. M., Jobsen, J. J., Lutgens, L. C. H. W., van der Steen‐Banasik, E. M., Nijman, H. W., Putter, H., Bosse, T., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2878 · Cited by 856
Cited by
Sorted by citations
Items 101–200 of 411
Shetty, A., & Suresh, P. S. (2021) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2021.105843 · Cited by 16
Liang, J., Sun, W., Song, H., Wang, C., Li, Q., Li, C., Wei, D., Zhao, Y., Li, C., & Zhang, H. (2021) · Epigenomics · doi:10.2217/epi-2021-0218 · Cited by 17
The Role and Applications of Exosomes in Gynecological Cancer: A Review
Wang, K., & Ding, D. (2023) · Cell Transplantation · doi:10.1177/09636897231195240 · Cited by 17
Zhang, Q., Zhu, F., Yin, T., Shi, D., & Zhang, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-69233-6 · Cited by 17
Aimagambetova, G. N., Terzic, S., Laganà, A. S., Bapayeva, G., la Fleur, P., & Terzić, M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm11010196 · Cited by 17
Factors contributing to the delayed diagnosis of endometriosis—a systematic review and meta-analysis
Li, W., Feng, H., & Ye, Q. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1576490 · Cited by 25
Arend, R. C., Goel, N., Roane, B. M., Foxall, M. E., Dholakia, J., Londoño, A. I., Wall, J. A., Leath, C. A., & Huh, W. K. (2021) · Gynecologic Oncology · doi:10.1016/j.ygyno.2021.07.017 · Cited by 16
Wei, S., Zhang, J., Shi, R., Yu, Z., Chen, X., & Wang, H. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.944000 · Cited by 16
MicroRNA-372 acts as a double-edged sword in human cancers
Tajik, F., Alian, F., Yousefi, M., Azadfallah, A., Hoseini, A., Mohammadi, F., Karimi-Dehkordi, M., & Alizadeh‐Fanalou, S. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e15991 · Cited by 16
Advances and challenges in the use of liquid biopsy in gynaecological oncology
Zhang, Y. X., & Tian, L. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e39148 · Cited by 16
Chen, Y., Lee, K., Liang, Y., Qin, S., Zhu, Y., Liu, J., & Yao, S. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.763537 · Cited by 16
Roles of Pyroptosis-Related Gene Signature in Prediction of Endometrial Cancer Outcomes
Chen, Y., Liao, Y., Du, Q., Shang, C., Qin, S., Lee, K., Zou, Q., Liu, J., & Yao, S. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.822806 · Cited by 16
The Interplay of Tumor Stroma and Translational Factors in Endometrial Cancer
Sobočan, M., Smolle, M., Schatz, C., & Haybaeck, J. (2020) · Cancers · doi:10.3390/cancers12082074 · Cited by 13
Urick, M. E., Yu, E., & Bell, D. W. (2021) · Cancer · doi:10.1002/cncr.33567 · Cited by 16
Self-citationPP2A and E3 ubiquitin ligase deficiencies: Seminal biological drivers in endometrial cancer
Bosquet, J. G., Bakkum-Gamez, J. N., Weaver, A. L., McGree, M. E., Dowdy, S. C., Famuyide, A. O., Kipp, B. R., Halling, K. C., Couch, F. J., & Podratz, K. C. (2021) · Gynecologic Oncology · doi:10.1016/j.ygyno.2021.04.008 · Cited by 15
Rao, Q., Liao, J., Li, Y., Zhang, X., Xu, G., Zhu, C., Tian, S., Chen, Q., Zhou, H., & Zhang, B. (2022) · Cancer Medicine · doi:10.1002/cam4.5363 · Cited by 15
Yang, Y., Sun, L., Chen, Z., Liu, W., Xu, Q., Liu, F., Ma, M., Chen, Y., Lü, Y., Fang, H., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1033497 · Cited by 16
Xin, W., Wang, Y., Hua, K., & Liu, S. (2023) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2023.5276 · Cited by 15
Combined Inhibition of PI3K and STAT3 signaling effectively inhibits bladder cancer growth
Peng, W., Zhang, H., Yin, M., Kong, D., Kang, L., Teng, X., Wang, J., Chu, Z., Sun, Y., Long, P., et al. (2024) · Oncogenesis · doi:10.1038/s41389-024-00529-y · Cited by 15
Tailored Therapy Based on Molecular Characteristics in Endometrial Cancer
Lee, S. (2021) · BioMed Research International · doi:10.1155/2021/2068023 · Cited by 15
circSLC6A6 Sponges miR-497-5p to Promote Endometrial Cancer Progression via the PI4KB/Hedgehog Axis
Hu, J., Peng, X., Du, W., Huang, Y., Zhang, C., & Zhang, X. (2021) · Journal of Immunology Research · doi:10.1155/2021/5512391 · Cited by 15
Glycosylation and its research progress in endometrial cancer
Pu, C., Biyuan, Xu, K. L., & Zhao, Y. (2022) · Clinical & Translational Oncology · doi:10.1007/s12094-022-02858-z · Cited by 15
Fan, C.-T., Hsu, S., Sun, L., Hwang, S.-F., Liu, C.-K., Shih, Y., Chen, M.-J., Li, H., Wang, J., Wen, M., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12020603 · Cited by 14
O‑GlcNAcylation mediates endometrial cancer progression by regulating the Hippo‑YAP pathway
Zhai, L., Yang, X., Dong, J., Qian, L., Gao, Y., Lv, Y., Chen, L., Chen, B., & Zhou, F. (2023) · International Journal of Oncology · doi:10.3892/ijo.2023.5538 · Cited by 14
Ma, L., Huang, W., Liang, X., Bai, G., Wang, X., Jiang, H., Yang, X., Hu, L., Chen, X., & Liu, C. (2023) · Cancer Science · doi:10.1111/cas.15900 · Cited by 14
Spencer, N., Sanchez, A. L. R., Gopalam, R., Subbarayalu, P., Medina, D., Yang, X., Ramirez, P. R., Randolph, L., Aller, E. J., Santhamma, B., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417426 · Cited by 14
Novel Molecular Targets in Endometrial Cancer: Mechanisms and Perspectives for Therapy
Pina, P. S., & Lheureux, S. (2024) · Biologics · doi:10.2147/btt.s369783 · Cited by 14
Kim, J. H., Han, K. H., Park, E. Y., Kim, E. T., Kim, E. J., Tan, D. S. P., Lee, J.-Y., Park, S., Fotopoulou, C., & Lim, M. C. (2024) · Gynecologic Oncology · doi:10.1016/j.ygyno.2024.05.006 · Cited by 14
Cheng, Y., Li, X., Dai, Y., Dong, Y., Yang, X., & Wang, J. (2021) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2021.32.e30 · Cited by 14
Lin, C., Liu, S., Wu, Z.-S., Wang, Y., & Huang, S. (2021) · Life · doi:10.3390/life11020160 · Cited by 14
Meijuan, C., Liu, F., Min, F., & Wang, Q. (2022) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2022.106274 · Cited by 14
Li, Y., Chen, R., Yuan, M., Wang, D., Fu, C., Chen, R., Lei, C., & Zhou, Q. (2022) · International Journal of Cancer · doi:10.1002/ijc.34241 · Cited by 14
An Updated Review of the Anticancer Mechanisms and Therapeutic Potential of Naringenin
Noman, A. M., Sultan, M. T., Raza, H., Imran, M., Hussain, M., Mujtaba, A., Mostafa, E. M., Ghoneim, M. M., Selim, S., Jaouni, S. K. A., et al. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.70626 · Cited by 13
Li, Y., Feng, J., Zhao, C., Lin, M., Shi, S., Liu, K., & Ma, J. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-3446 · Cited by 14
Hsin, I., Wu, P., Tang, S., Ou, C., Chang, H. H., Shen, H., Ko, J., & Wang, P.-H. (2023) · Journal of Cellular Physiology · doi:10.1002/jcp.31103 · Cited by 13
Endometrial cancer—is our knowledge changing?
Králíčková, M., Větvička, V., & Laganà, A. S. (2020) · Translational Cancer Research · doi:10.21037/tcr-20-1720 · Cited by 13
Hu, Z., Cai, B., Wang, M., Wen, X., Geng, A., Hu, X., Xue, R., Mao, Z., Jiang, Y., & Wan, X. (2020) · Cell Cycle · doi:10.1080/15384101.2020.1831257 · Cited by 13
Hu, Y., Zheng, M., Zhang, D., Gou, R., Liu, O., Wang, S., & Lin, B. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02215-0 · Cited by 13
O'Connor, C. M., Taylor, S. E., Miller, K., Hurst, L., Haanen, T. J., Suhan, T. K., Zawacki, K. P., Noto, F. K., Trako, J., Mohan, A., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-1987 · Cited by 13
Cong, Y., Qi, H., Zhang, Y., Zhao, W. T., & Wu, G. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2021.764194 · Cited by 13
Wang, B., Wang, B., Ma, J., He, J., Wang, Z.-H., Li, Q., & Ma, X. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06564-2 · Cited by 12
Zhang, P., Li, P., Tang, M., Gimple, R. C., Huang, L., Yue, J., Shen, Q., Du, Y., Zhang, Q., Yang, Z., et al. (2024) · Science China Life Sciences · doi:10.1007/s11427-024-2622-1 · Cited by 12
Hu, Z., Tang, M., Huang, Y., Cai, B., Sun, X., Chen, G., Huang, A., Li, X., Shah, A. R., Jiang, L., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58317-0 · Cited by 12
Zhou, H., Zou, X., Li, H., Li, T., Chen, L., & Cheng, X. (2020) · Oncology Letters · doi:10.3892/ol.2020.11885 · Cited by 12
Liquid Biopsy for Monitoring EC Patients: Towards Personalized Treatment
Piñeiro-Pérez, R., Abal, M., & Muinelo‐Romay, L. (2022) · Cancers · doi:10.3390/cancers14061405 · Cited by 13
Characterization of Epigenetic and Molecular Factors in Endometrium of Females with Infertility
Skliutė, G., Baušytė, R., Ramašauskaitė, D., & Navakauskienė, R. (2022) · Biomedicines · doi:10.3390/biomedicines10061324 · Cited by 12
Hongxiang, Y., Li, A., Li, A., Zhao, F., & Zhang, T. (2022) · Medicine · doi:10.1097/md.0000000000029686 · Cited by 12
Chen, S., Liang, Y., Shen, Y., & Wang, X. (2023) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2023.11858 · Cited by 12
Natural products modulate cell apoptosis: a promising way for treating endometrial cancer
Zhou, X., Zeng, Y., Zheng, R., Wang, Y., Li, T., Song, S., Zhang, S., Huang, J., & Ren, Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1209412 · Cited by 12
Wang, Y., Sun, Y., Sun, F., Pin, H., Fan, R., & Ren, F. (2023) · Discover Oncology · doi:10.1007/s12672-023-00820-1 · Cited by 12
Urick, M. E., & Bell, D. W. (2020) · Cancer Medicine · doi:10.1002/cam4.3013 · Cited by 11
Self-citationSun, D., Zhao, H., Zhou, H., Tao, J., Li, T., Zhu, J., & Hou, H. (2023) · Translational Oncology · doi:10.1016/j.tranon.2023.101685 · Cited by 11
The prognostic value of co-expression of stemness markers CD44 and CD133 in endometrial cancer
Jiang, P., Tian, C., Zheng, Y., Gong, C., Wang, J., & Liu, Y. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1338908 · Cited by 11
Guo, Q., Tang, S., Ju, X., Feng, Z., Zhang, Z., Peng, D., Liu, F., Du, H., Wang, J., Zhang, Y., et al. (2024) · ESMO Open · doi:10.1016/j.esmoop.2024.103710 · Cited by 11
Rahman, M. F., Rahman, M. R., Islam, T., Zaman, T., Shuvo, M. A., Hossain, M. T., Islam, M. R., Karim, M. R., & Moni, M. A. (2019) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2019.100274 · Cited by 11
Rahman, F., Mahmud, P., Karim, R., Hossain, M. T., & Islam, F. (2020) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2020.100376 · Cited by 11
Dai, Y., Wang, J., Zhao, L., Wang, Z., & Wang, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.634857 · Cited by 11
Bednaříková, M., Bretová, P., Gottwaldová, J., Ovesná, P., Hausnerová, J., Minář, L., Felsinger, M., Valík, D., Čermáková, Z., & Weinberger, V. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10122640 · Cited by 11
Application of Extracellular Vesicles in Gynecologic Cancer Treatment
Zhang, R., Zou, Y., & Luo, J. (2022) · Bioengineering · doi:10.3390/bioengineering9120740 · Cited by 11
Lai, J., Xu, T., & Yang, H. (2022) · BMC Cancer · doi:10.1186/s12885-022-09402-w · Cited by 11
Ying, M., Ma, R., Zhang, Z., Jiang, H., Li, Y., Jiang, S., & Li, Y. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c00042 · Cited by 10
Lou, M., Zou, L., Zhang, L., Lu, Y., Chen, J., & Zong, B. (2024) · Molecular Medicine · doi:10.1186/s10020-024-00946-0 · Cited by 10
Wang, Y., Zheng, Y., Tian, C., Yu, J., Rao, K., Zeng, N., & Jiang, P. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s494716 · Cited by 10
Jiang, S., Ye, M., Wan, J., Ye, Q., Qiu, S., Yang, Y., & Li, X. (2025) · Cancer Medicine · doi:10.1002/cam4.70584 · Cited by 10
Tan, X., Chen, D., Guo, S., Wang, Y., Zou, Y., Wu, Z., Zhou, F., Qin, Z., Liu, Z., Cao, Y., et al. (2020) · Theranostics · doi:10.7150/thno.51725 · Cited by 10
Cuproptosis patterns and tumor microenvironment in endometrial cancer
Chen, J., Wang, G., Luo, X., Zhang, J., & Zhang, Y. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.1001374 · Cited by 10
Li, Q., Lai, L., Wang, H., Zhang, Y., Qian, X., & He, D. (2022) · Cancer Management and Research · doi:10.2147/cmar.s370477 · Cited by 10
Zhou, X., Dai, H., Zhang, H., Zhu, J., & Hu, H. (2022) · BioMed Research International · doi:10.1155/2022/2056913 · Cited by 10
RetractedShu, W., Teng, H., Xin, X., Zhang, J., Lin, J., Shi, R., Zhao, R., Zhang, W., Dong, K.-J., Wang, H., et al. (2024) · Carcinogenesis · doi:10.1093/carcin/bgae059 · Cited by 9
Mitophagy in gynecological malignancies: roles, advances, and therapeutic potential
Wang, J., & Wang, D. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02259-x · Cited by 9
The roles and clinical applications of interleukins in endometrial carcinoma
Zang, Y., Li, H., Liu, S., Zhao, R., Zhang, K., Zang, Y., Wang, Y., & Xue, F. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1001693 · Cited by 11
Chen, J., Wang, G., Zhang, D., Luo, X., Zhang, D., & Zhang, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1075431 · Cited by 9
Wu, Q., Tian, R., Liu, J., Ou, C., Li, Y., & Fu, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1139126 · Cited by 9
Liang, C., Chen, Y., Chen, S., She, J., Shi, Q., & Wang, P. (2023) · Translational Cancer Research · doi:10.21037/tcr-23-697 · Cited by 9
PARP inhibitors and immunotherapy in ovarian and endometrial cancers
Miller, R. E., Lewis, A. J., & Powell, M. E. B. (2021) · British Journal of Radiology · doi:10.1259/bjr.20210002 · Cited by 11
Zhang, Q., & Huang, X. (2021) · PeerJ · doi:10.7717/peerj.11995 · Cited by 9
Improved long‐term survival of corpus cancer in Japan: A 40‐year population‐based analysis
Yagi, A., Ueda, Y., Ikeda, S., Miyoshi, A., Nakagawa, S., Hiramatsu, K., Kobayashi, E., Kimura, T., Ito, Y., Nakayama, T., et al. (2021) · International Journal of Cancer · doi:10.1002/ijc.33799 · Cited by 9
Knez, J., Sobočan, M., Magdalenić, U. B., Kavalar, R., Zupin, M., Büdefeld, T., Potočnik, U., & Takač, I. (2021) · Radiology and Oncology · doi:10.2478/raon-2021-0036 · Cited by 9
EZH2 and Endometrial Cancer Development: Insights from a Mouse Model
Fang, X. D., Ni, N., Wang, X., Tian, Y., Ivanov, I. V., Rijnkels, M., Bayless, K. J., Lydon, J. P., & Li, Q. (2022) · Cells · doi:10.3390/cells11050909 · Cited by 9
Li, Y., Tian, R., Liu, J., Ou, C., Wu, Q., & Fu, X. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.833910 · Cited by 9
Hsa_circ_0000437 Inhibits the Development of Endometrial Carcinoma through miR-626/CDKN1B Axis
Li, X., & Liu, Y. (2022) · Protein and Peptide Letters · doi:10.2174/0929866529666220622125016 · Cited by 9
Rivera, D., Paudice, M., Accorsi, G., Valentino, F., Ingaliso, M., Pianezzi, A., Roggieri, P., Trevisan, L., Buzzatti, G., Mammoliti, S., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12237236 · Cited by 9
Campeanu, I. J., Jiang, Y., Afisllari, H., Dzinic, S. H., Polin, L., & Yang, Z.-Q. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02147-6 · Cited by 8
Biomarkers and immunotherapy in endometrial cancer: mechanisms and clinical applications
Lianfang, Z., Xiao-hong, L., Jing, Y., Tang, L., Lin, F., Zhang, Y., Tang, Y., Chen, C., Yang, J., Liu, X., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1684549 · Cited by 10
Molecular Classification of Endometrial Carcinomas: Review and Recent Updates
Kumari, A., Kumar, H., Harvey, S. E., Xing, D., & Li, Z. (2025) · Cancers · doi:10.3390/cancers18010051 · Cited by 8
Guo, Q., Cui, H., Zhang, Y., Tang, S., Yan, W., Zhou, X., Ding, H., Zhou, J., Ju, X., Feng, Z., et al. (2026) · npj Precision Oncology · doi:10.1038/s41698-026-01280-w · Cited by 11
Tumor-derived ARHGAP35 mutations enhance the Gα13-Rho signaling axis in human endometrial cancer
Yagi, H., Onoyama, I., Asanoma, K., Kawakami, M., Maenohara, S., Kodama, K., Matsumura, Y., Hamada, N., Hori, E., Hachisuga, K., et al. (2022) · Cancer Gene Therapy · doi:10.1038/s41417-022-00547-1 · Cited by 7
Genomic profile of Chinese patients with endometrial carcinoma
Li, J., Li, X., Quan, C., Li, X., Wan, C., & Wu, X. (2023) · BMC Cancer · doi:10.1186/s12885-023-11382-4 · Cited by 8
Shi, S., Tang, X., & Liu, H. (2023) · Reproductive Sciences · doi:10.1007/s43032-023-01382-x · Cited by 8
Chang, C.-Y., Lu, Y.-C. (., Ting, W., Shen, T.-W., & Peng, W.-C. (2021) · Open Medicine · doi:10.1515/med-2021-0226 · Cited by 7
Dong, Y., Yin, A., Xu, C., Jiang, H., Wang, Q., Wu, W., & Guo, S. (2021) · Oncology Letters · doi:10.3892/ol.2021.12837 · Cited by 8
Shen, J., Feng, X., Wang, H., Wang, Y., & Zhou, Y. (2021) · Journal of Cancer · doi:10.7150/jca.62630 · Cited by 8
Glucose transporters: Important regulators of endometrial cancer therapy sensitivity
Zhang, X., Lu, J., Abudukeyoumu, A., Hou, D.-Y., Dong, J., Wu, J., Liu, L., Li, M., & Xie, F. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.933827 · Cited by 9
Alessandro, L., Low, K.-J. E., Abushelaibi, A. A., Lim, S. E., Cheng, W.-H., Chang, S.-K., Lai, K., Sum, Y. W., & Maran, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214285 · Cited by 8
van Weelden, W. J., Bretveld, R. W., Romano, A., van Erp, S., Engels, S., Lalisang, R. I., Pijnenborg, J. M. A., & van der Aa, M. A. (2021) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2021-002444 · Cited by 7
Prss29 Cre recombinase mice are useful to study adult uterine gland function
Kelleher, A. M., Allen, C. C., Davis, D. J., & Spencer, T. E. (2022) · genesis · doi:10.1002/dvg.23493 · Cited by 8
Wang, Z., Xing, L., Huang, Y., & Han, P. (2022) · Cancer Medicine · doi:10.1002/cam4.5119 · Cited by 7
Akın, D. F., & Özkan, D. (2023) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2022.09.010 · Cited by 7
Amiran, M. R., Taghdir, M., & Joozdani, F. A. (2023) · Journal of Molecular Modeling · doi:10.1007/s00894-023-05520-9 · Cited by 7
Pang, X., Li, F., Lu, M., & Zhu, L. (2023) · Journal of Cancer · doi:10.7150/jca.86325 · Cited by 7
Metadata
- Authors
- Urick, M. E., & Bell, D. W.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Bell, Daphne W.
- Venue
- Nature Reviews Cancer
- Published
- 2019-08-06
- Volume
- 19
- Issue
- 9
- Pages
- 510-521
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC7446243
- OpenAlex
- W2965204233
- Cited by
- 405
- References
- 157
- Citations by year
- 2026: 19 · 2025: 57 · 2024: 58 · 2023: 70 · 2022: 101 · 2021: 66 · 2020: 32 · 2019: 2
- FWCI
- 8.14
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (Z99 HG999999)
- National Human Genome Research Institute (Z01HG200338, ZIAHG200379, ZIAHG200338)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Keywords
- endometrial cancer, molecular subtyping, molecular targets, targeted therapy, early detection, risk stratification, endometrioid carcinoma, serous carcinoma, clear cell carcinoma, histological subtypes, prognosis
- MeSH terms
- Animals, Carcinoma, Female, Humans, Immunotherapy, Mutation, Prognosis, Risk, Sarcoma, Biomarkers, Tumor, Endometrial Neoplasms, Risk Assessment, Proteomics, Mice, Translational Research, Biomedical
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
